Biocon Biologics  /  News

OVERVIEW

We recognise that regular, effective, balanced and timely communication is important to help us maintain our credibility as a trusted brand. In this section we provide company information related to key business developments, achievements, regulatory approvals, recognitions & felicitations. We also share our brand stories, and corporate information toolkit.

Leveraging THE POWER OF ONE

Biocon Biologics has acquired the global biosimilars business of Viatris to become a Unique, World-Class, Fully Integrated Biosimilars Leader.

We are enabling affordable access to lifesaving biosimilars worldwide.

RESOURCE CENTRE

SOCIAL MEDIA

LINKEDIN

BIOCON BLOG

Share
buy twitter followers